BridgeMD
New treatment option for Gynecologic Cancers
Official title eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer
ClinicalTrials.gov ID: NCT06619769
What this study is testing
- What it's testing
- Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older, women only
You may be able to join if
- self-report a current or history of gynecologic cancer of any subtype
- self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised
- are fluent in English (eSense content is delivered in English)
- have reliable internet access and basic competency in using online platforms (individuals will self-report)
- are available for 8 - 16 weeks and able to complete eSense modules and associated questionnaires
You likely can't join if
- have visual impairments or disabilities interfering with reading and ability to interact with online materials
- have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening)
- individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).
See the full eligibility criteria
- self-report a current or history of gynecologic cancer of any subtype
- self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised
- are fluent in English (eSense content is delivered in English)
- have reliable internet access and basic competency in using online platforms (individuals will self-report)
- are available for 8 - 16 weeks and able to complete eSense modules and associated questionnaires
- any gender
- have visual impairments or disabilities interfering with reading and ability to interact with online materials
- have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening)
- individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).
The study team makes the final eligibility decision.
Where it's taking place
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.